ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

Breast Cancer Reports “Informative,” More Research Is Needed: Gullino

December 3, 1976

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Moffitt, Ohio State Form Network, Invite Major Cancer Centers to Join

May 30, 2014

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991